Study of PTC844 in Participants With Active Rheumatoid Arthritis
NCT07779616
This study is recruiting at 6 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
This study is designed to assess the safety, pharmacokinetics (PK), and biomarker effects of PTC844 compared to placebo in participants with active rheumatoid arthritis (RA).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Rheumatoid Arthritis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- PTC Therapeutics
- Last updated on ClinicalTrials.gov
- November 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- AARA Clinical Research - Arizona Arthritis and Rheumatology Associates - Chandler · Chandler, AZ
California · 1
- Millennium Clinical Trials · Westlake Village, CA
Florida · 3
- Nouvelle Clinical Research LLC · Cutler Bay, FL
- Millennium Medical Research, LLC. · Miami, FL
- Conquest Research · Winter Park, FL
Texas · 1
- Precision Comprehensive Clinical Research Solutions - Irving · Irving, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.